Tinzaparin

The characteristics to be taken into account when selecting a power supply are: - the required output voltage and current, - the mains voltage available in the installation. An initial selection can be made using the table opposite. This may however result in several products being selected as suitable. Other selection criteria must therefore be taken into account. b The quality of the mains power supply The Phaseo range is the solution because it guarantees precision to 3% of the output voltage, whatever the load current and the input voltage. In addition, the wide input voltage range of Phaseo power supplies allows them to be connected to all mains supplies within the nominal range, without any adjustment. The Phaseo RP family can also be connected to c 110 and 220 V emergency supplies. b Harmonic pollution power factor ; The current drawn by a power supply is not sinusoidal. This leads to the existence of harmonic currents which pollute the mains supply. European standard EN 61000-3-2 limits the harmonic currents produced by power supplies. This standard covers all devices between 75 W and 1000 W, drawing up to 16 per phase, and connected directly to the public mains power supply. Devices connected downstream of a private, low voltage general transformer are therefore excluded. Regulated switch mode supplies always produce harmonic currents; a filter circuit Power Factor Correction or PFC ; must therefore be added to comply with standard EN 61000-3-2. Phaseo ABL-7RP and ABL-7UPS power supplies conform to standard EN 61000-3-2 and can therefore be connected directly to public mains power supplies. b Electromagnetic compatibility Levels of conducted and radiated emissions are defined in standards EN 55011 and EN 55022. The majority of products in the Phaseo range have class B certification and can be used without any restrictions due to their low emissions. ABL-7CEM24003 and ABL-7CEM24006 power supplies have class A certification. It is recommended that they should not be used in the following equipment: trains, aircraft, nuclear applications and in any environment where malfunctioning could cause serious injuries or lead to death. These products are designed for use in industrial equipment and are not suitable for use in residential environments. b Behaviour in the event of short-circuits Phaseo power supplies are equipped with an electronic protection device. This protection device resets itself automatically on elimination of the fault around 1 second for ABL-7 RE RP, around 3 seconds for ABL-7 UE UP REQ ; which avoids having to take any action or change a fuse. In addition, the Phaseo ABL-7RP U REQ ranges allow the user to select the reset mode in the event of a fault: - in the "AUTO" position, resetting is automatic, - in the "MANU" position, resetting occurs after elimination of the fault and after switching the mains power off and back on. This feature allows Phaseo ABL-7RP U REQ power supplies to be used in installations where the risks associated with untimely restarting are significant.
Coffee tables, couches, dressers, beds, outdoor settings, homewares, antiques, PLUS lots of Christmas gift ideas. Also exhibiting amazing works from LOCAL ARTISTS.
Administration iv side effects bleeding problems low platelets , due to a low level of structural similarity between danaparoid and heparin asthma exacerbations, due to allergies to sulphites contained within the medicine antithrombotics thrombolytics , anticoagulants , and antiplatelet drugs ; b01 ; edit acenocoumarol , clorindione , dicumarol dicoumarol ; , diphenadione , ethyl biscoumacetate , phenprocoumon , phenindione , tioclomarol , warfarin antithrombin iii , bemiparin , dalteparin , danaparoid , enoxaparin , heparin , nadroparin , parnaparin , reviparin , sulodexide , tinzaparin abciximab , acetylsalicylic acid aspirin ; , aloxiprin , beraprost , ditazole , carbasalate calcium , cloricromen , clopidogrel , dipyridamole , epoprostenol , eptifibatide , indobufen , iloprost , picotamide , prasugrel , ticlopidine , tirofiban , treprostinil , triflusal alteplase , ancrod , anistreplase , brinase , drotrecogin alfa , fibrinolysin , protein c , reteplase , saruplase , streptokinase , tenecteplase , urokinase argatroban , bivalirudin , dabigatran , desirudin , hirudin , lepirudin , melagatran , ximelagatran dabigatran , defibrotide , dermatan sulfate , fondaparinux , rivaroxaban citrate , edta , oxalate this pharmacology -related article is a stub. In addition Smith's operates 5 Smith's Marketplace Stores all located in Utah ; and one Price Rite grocery warehouse operating in New Mexico ; . Store operations are managed from offices in the company's home base of Salt Lake City. Smith's dedication to the interests of the Utah community remains steadfast. In 2005, Smith's donated million to Utah schools through the Earn & Learn program and 0, 000 for charity patient care at Primary Children's Medical Center.

9-6. EXCEPTIONS TO THE ACT Some patients that is, those who have arthritis ; may find child-resistant packaging too difficult to open. Furthermore, some patients for example: those with certain types of heart conditions ; may wish to obtain their medications from the container in a short period of time when they need them. For these types of patients, alternatives to child--resistant packaging are available. a. Nitroglycerin Must NOT be Dispensed in Child--Resistant Packaging. This drug is for patients who have certain types of heart conditions. These patients must be able to obtain their nitroglycerin quickly in the event they need it. b. Alternative Packaging. The manufacturer can market one size of a product in conventional not child-resistant ; packaging--if the same product is also available in child-resistant packaging. However, the conventional packaging must have a label which clearly states: This packaging for household without young children or if the package is small: Package not child-resistant c. Patient or Physician Request. The patient or prescribing physician may request that prescription medicines be put into ordinary packaging without safety features. Although some pharmacists may ask for a written statement from a patient before providing a conventional closure, this is not a requirement of the Federal law. 9-7. CONSIDERATIONS FOR THE OUTPATIENT PHARMACY Child--resistant packaging has been in use for quite some time. It has, without a doubt, decreased the number of cases of accidental poisonings. If you have purchased items or received prescriptions packaged in child-resistant containers, you are aware of the advantages and disadvantages of this means of preventing accidental poisonings. In your position in the pharmacy, you may hear comments about the packaging. Some patients are quick to complain about the packaging. Here are some considerations about the act that are pertinent to you: a. You should be very familiar with your pharmacy's policies regarding childresistant packaging. For example, if a patient requests conventional packaging for a prescription item, does your pharmacy require the patient to sign or initial the prescription or a special form? You should carefully read and study your local Standing Operating Procedures SOP ; to insure you do what is required. b. Some patients may request conventional packaging. Suppose a retired individual asks you to package his prescription in a conventional container. Does this person have grandchildren who frequently come to the home? Remember, many.
14 [P1-386] The Evaluation of Biochemical Indexes of Acromegalic Renato Cozzi, Roberto Attanasio, Silvia Abstract Disease Activity Must Be Gender- and Age-Dependent. Grottoli, Giorgio Pagani, Daniela Dallabonzana, Valentina Gasco, Alberto Pedroncelli, Marcella Montini, Paola Loli, Ezio Ghigo 15 [P1-427] Effects of 1-year Treatment with MK-677 on 24-h Mean GH Levels and Body Composition in Healthy Older Men: A Double-Blind, Placebo-Controlled, Crossover Study of an Orally Active GH Secretagogue. 16 [P3-460] AMS Aging Male's Symptoms Rating Scale ; , a Valuable Tool To Detect Testosterone Efficiency and Follow Testosterone Treatment in the Aging Male. Ralf Nass, Suzan S Pezzoli, Jody L Clasey, Mary A Clancy, Jim Patrie, Frank Harrell, Mary L Vance, Michael O Thorner Abstract and tipranavir.

There is a risk that a patient has been dispensed a counterfeit medicine, then it is vital that they are informed. There have been two recent cases in Great Britain where counterfeit medicines appeared in the legitimate pharmacy supply chain. The public announcement of the problem of the counterfeit medicines was therefore entirely proper and necessary." He added, "It is important that news stories of this type are handled responsibly so that the public's confidence in their medicines is not undermined. This could deter patients from taking genuine medicines." This assessment, that the dangers of causing alarm amongst the general public could outweigh the benefits of disclosure, remains widespread in public statements. A spokesperson for the Association of British Pharmaceutical Industries, Marjorie Syddall, wrote E-mail letter, 20 October 2003 ; , "A company should be completely satisfied that a medicine is counterfeit before informing the authorities, but more importantly still, before it makes this information known to the public--so that no unnecessary alarm is caused. WHY select ANALOGUES? The limitations of soluble human insulin: Hexamer formation and slow dissociation into dimers and monomers extend the onset of action in subcutaneous- administered soluble human insulin. This means that soluble human insulin is recommended to be injected approx. 30 minutes before a meal, allowing insulin monomers to reach the circulation before glucose levels rise. This restriction is inconvenient for people with diabetes, and actually, many people with diabetes do not comply with the recommended 30-minute interval for insulin injection before meals, but often administer their insulin shortly before mealtimes and tobi. Statements contained in this presentation, other than historical facts, are "forward-looking statements" as such term is defined in the Private Securities Litigation Reform Act of 1995 ; . These statements are based on currently available information, on current best estimates, and on assumptions believed to be reasonable. This information, these estimates and assumptions may prove to be incomplete or erroneous, and involve numerous risks and uncertainties, beyond the Company's control. Hence, actual results may differ materially from those expressed or implied by such forward-looking statements. All mentions and descriptions of Recordati products are intended solely as information on the general nature of the company's activities and are not intended to indicate the advisability of administering any product in any particular instance. Recordati, established in 1926, is a European pharmaceutical group, listed on the Italian Stock Exchange Reuters RECI , Bloomberg REC IM, ISIN IT 0003828271 ; , dedicated to the research, development, manufacturing and marketing of pharmaceuticals, with headquarters in Milan, Italy, operations in the main European countries, and a total staff of over 2, 000. A European field force of over 1, 000 medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas. Recordati's current and growing coverage of the European pharmaceutical market makes it a partner of choice for new product licenses from companies which do not have European marketing organizations. Recordati is committed to the research of new drug entities within the cardiovascular and urogenital therapeutic areas in which its research team has proven scientific competence and a track record of discovery and development of original drugs, the most recent of which, lercanidipine, a latest generation calcium channel blocker for the treatment of hypertension, is the company's leading product. Consolidated revenue for 2006 was 576.2 million, operating income was 120.3 million and net income was 74.0 million. Is believed that this flock is one of only a few that visit the UK each year. Greenland whitefronted geese are an EC Birds Directive Annex 1 species. Under this Directive, Annex 1 species "shall be the subject of special conservation measures concerning their habitat in order to ensure their survival and reproduction in their area". Tir Cymen funding also allowed the 13 hectares of broadleaved woodland on the farm to be fenced to exclude livestock. Removing grazing encourages woodland ground flora and the natural regeneration of trees. Once the flora has started to recover, the associated fauna will also start to return. Common species such as the speckled wood butterfly Pararge aegeria ; , wood mouse Apodemus sylvaticus ; and bank vole Clethrionomys glareolus ; will return quickly as there will be populations nearby. Rarer woodland species may never re-establish themselves because the distance from the nearest population is too great. Without the Tir Cymen scheme, these woodland areas would still be grazed by stock, thus preventing natural regeneration as the young tree seedlings are eaten. Over time, as trees died and were not replaced, the wooded area would have slowly reverted to grassland and tolcapone. The FIGO Save the Mothers Initiative, an Ethio-Swedish project 1 ; 2 ; 3 ; Mller, B Odlind V , Lindmark G Departments of Obstetrics & Gynecology, 1 ; Mlarsjukhuset, Eskilstuna, 2 ; Karolinska Sjukhuset, Stockholm, 3 ; Akademiska Sjukhuset, Uppsala, Sweden bo.mller telia Background. At the Copenhagen conference 1997 a FIGO initiative invited societies for obstetrics and gynaecology of developing and developed countries to apply for participation and formulation of projects to significantly reduce maternal mortality. Four projects with "twinned" societies were subsequently launched by FIGO, one of which with the Ethiopian ESOG ; and Swedish SFOG ; societies. Aim. Co-operation of the Ob Gyn societies in improving maternity services. The project focused on improving emergency obstetric services in Ambo district, a rural area 120 km west of Addis Ababa with a population of 2.5 million and well over 100, 000 deliveries annually and an estimated maternal mortality of 1000. Design. Major project components included training of staff of Ambo hospital and two health centres, provision of equipment, establishing an outpatient pharmacy and blood services, strengthening of documentation and reporting, and regular supervision. The FIGO secretariat under a Steering Committee monitored the project. Outcome was given in proxy indicators of maternal mortality, such as admissions with life-threatening complications and number of life-saving procedures, notably numbers of caesarean sections. Implementation. Communication between the two participating societies was difficult throughout the project. Provision of equipment was late and Ambo staff turnover necessitated repeated batches to be trained. The war with Eritrea adversely affected the project as Ethiopia's national priorities shifted. Results. From 1998 to 2000 Ambo hospital deliveries increased from 700 to 850 in 2000, complicated deliveries from 260 to 320 and the number of caesarean sections from 30 to 120. Referral of patients to Addis Ababa for caesarean sections virtually stopped. Serious limitations were uncontrolled and high turn-over of staff, hardly any increase of facility use and total patient load, lack of drugs and supplies, absence of hospital management autonomy, limited improvement of documentation and unsatisfactory blood services. Conclusion. This experience may be used for future projects. To affect maternal mortality, emphasis needs to be placed on emergency obstetrical care and issues relating to hospital service management, drugs and supplies, staffing and training, must be dealt with. Regional and community involvement in order to increase utilization of health services need to be addressed. The success of a project must be judged by relating outside input to the resources available for health care in the country. Overall health expenditure per capita in Ambo 1994 95 ; was US$ 0.5. The Ambo project added a budget of US$ 241 000. There is a desperate need for a wise use of funds to improve reproductive health care and obstetric services. Societies for obstetrics and gynecology have an obligation to find ways to promote reproductive health at home and abroad.

Of nine performance indicators for the SWC component of the programme, at the goal, purpose, and output level. This set of performance indicators, meant to inform the donor, did not replace the more detailed internal planning and monitoring by the CMDT Lanser, 1997; Schrader, 1997 ; . Planning at the goal level The goal of the SWC project in southern Mali was composed of three aspects PLAE, 1986; PLAE, 1989; CMDT, 1995 ; : To reduce land degradation To intensify agriculture To increase agricultural production When the SWC project continued as SWC programme in 1996, the overall goal changed slightly: to contribute to economic and ecologic sustainable development in southern Mali. Initially no quantitative targets were set at the goal level. The rationale behind this was that attribution of change to the project would be too difficult because many other, non-project factors affect the indicators at the goal level. In 1993, propositions for a new monitoring and evaluation system were made, based on a logical framework, but no impact indicators were included either van Mourik et al., 1993 ; . Following the three aspects of the original goal, I examine the availability of indicators, baseline data and targets. Land degradation was not covered by indicators in the project or programme planning. Baseline data on land degradation are scarce. Jansen and Diarra 1992 ; have undertaken a qualitative study on trends in land use and land degradation in a few villages in southern Mali between 1952 and 1987. A detailed mapping of soils and vegetation was done PIRT, 1983 ; but this was not translated into an erosion risk mapping. The SWC project targeted villages with more severe erosion problems. Hence, specific baseline data on land degradation would be needed from targeted and non-targeted villages. No targets were set on how much land degradation should be reduced. Agricultural intensification was covered by two of the performance indicators agreed on in 1996 ; : cotton fertiliser dose and cultivated area per person. The values for 1996 served as baseline data and targets were set for 1997 and 1998. The cultivated area per person should not increase any further, and chemical fertiliser doses on cotton should increase. Agricultural production was not covered by indicators in the project or programme planning, so no baseline values or targets were set by the SWC project. Because crop yields were probably lower in targeted villages, specific baseline crop yields would have been needed. Planning at the purpose level The core project purpose was the management of natural resources by the rural population. This included the adoption of SWC measures, a balance between agro-, sylvo- and pastoral land use, and the management of communal land by village institutions. Supporting project purposes were capacity building of the extension service, awareness raising of the rural population for natural resource management, and documenting project experiences PLAE, 1989 ; . The focus in the.

And 8.1 ; . However, the other known four-helix bundle cytokines known to share a similar fold with IL-4, e.g. human growth hormone 60 ; 2 2.3 ; and GM-CSF 61 ; Z 2.3 ; faired no better than some globin sequences Kuroda's and slug sea hare globin, Z 5.0 and 4.8 ; that adopt a distinct tertiary structure. The results for the human and sheep Epo sequences were also ambiguous 2 1.6 and 0.8 ; . These results suggest that while profile methods are a powerful tool for recognizing structural similarity, their failure to identify homology does not exclude the possibility that two proteins share acommon fold. For distantly related unrelated strucor tures, current profile methods cannotreplace de nouo methods for tertiary structure prediction. Design and Expression of Epo Muteins That Test the Proposed Structure To test the proposed four a-helical bundle structure of erythropoietinand at the same time to attempt to locate functional domains, we created by site-directed mutagenesis a series of deletion, insertion, and replacement mutants. These muteins were designed to analyze the principal predicted structural featuresof the molecule: a-helices, interconnecting loops, as well as the NH2 and COOH termini. Structural and functional implications of the disulfide bridges and the glycosylation sites were also investigated. a-Helices-Short amino acid deletions were prepared in, or close to, the predicted A, B, C, and D a-helices. Human wild type and muteins were transiently expressed in cos7 cells. Northern blot analyses demonstrated that all the mutant plasmids produced about the same amount of mRNA as that of the wild type data not shown ; . Yet, no detectable amount of Epo protein could be found in the cos7 supernatants, either by radioimmunoassay or by bioassay using various Epo-dependent cell lines. Table I1 summarizes these findings. An example of SDS-polyacrylamide gel electrophoresis of immunoprecipitants from in uiuo %Slabeling is presented in Fig. 2. As expected, when cos7 cells were transfected with pSG5-EPO WT, a 35-37 kDa band was detected in the supernatant. In contrast, the deletion mutants Table 11 ; could be detected in cellular extracts but were not exported from the cells. Fig.2 shows the cytoplasmic retention of the mutein A140-144, lacking 4 residues in the middle of the predicted D-helix. The apparentmolecular mass - 28 kDa ; is less than expected for a 5-amino acid deletion. Therefore, not only the secretion, but also the glycosylation, seem to be impaired. None of these muteins had deletion of glycosylation sites. It is likely that full glycosylation of Epo requires conservation of its molecular architecture. Similar results reported in Table 11 ; were obtained for all the muteins having partial deletion of an a-helical peptide segment. Because contaminants in crude cos7 cellular extracts severely interfere with the radioimmunoassay, no direct Epo quantitation was possible. However, aliquots of hypotonic extracts of cos7 transfected with wild type Epo were able to sustain HDC57 proliferation. No similar biological activity was found for muteins with limited deletion of a-helices. Interconnecting Loops-The peptide segment joining Aand B-helices presents several interesting features Fig. 3A ; . AB loop consists of 36 amino acids. Two N-glycosylation sites and a small disulfide bridge are located in the first half and their biological implications will be discussed later. The COOH end of the AB loop contains a stretch of amino acids that is strongly conserved among mammals 26 ; . Alignments of human, monkeys, cat, mouse, rat, pig, and sheep Epos showed a consensus sequence: DTKVNFYAWKR M I ; E residues 43-57 ; . Three deletions were constructed. The expanding usage and prolonged administration of the approved HBV RT inhibitors as well as the development of new agents place an increasing emphasis on the monitoring and identification of new drug resistance mutations in antiviral therapy. Evaluation of the in vitro drug susceptibility of resistance-associated mutations forms a crucial component of any resistance surveillance program. Phenotypic analysis of HBV and tracleer and tinzaparin. The FLC provides education and training on all aspects of T2 to laboratory personnel. This service includes fundamentals, intermediate, and advanced training courses offering continuing education units CEUs a wide range of publications and resources; a training resources database; and an online T2 curriculum. N nebulised solutions precipitating acute angle closure glaucoma .25 nebuliser solutions compatibilities.23 non-steroidal anti-inflammatory drug interaction with ACE inhibitors.14 interaction with warfarin .56 O omeprazole Losec ; infusion acid suppression .71 gastrointestinal bleeding .71 omeprazole administration acid suppression .71 gastrointestinal bleeding .71 omeprazole intravenous administration .71 P Pabrinex administration.53 pamidronate.52 Parvolex.26 penicillins cross-reactions with cephalosporins .38 phenytoin dose equivalents .32 interaction with nasogastric feeds .31 phytomenadione reversal of anticoagulation .17 potassium peripheral administration.64 pravastatin time of administration .18 prednisolone .45 pregnancy treatment of threadworm infection.39 use of LMWHs .10 prochlorperazine intravenous administration . 63 R ranitidine intravenous administration .67 rosuvastatin time of administration .18 S simvastatin time of administration .18 statins time of administration .18 subcutaneous rehydration .48 T thomboprophylaxis in pregnancy .10 threadworm infection treatment in pregnancy .39 thyroxine .47 tinzaparin obese patients.5 sites of administration .8 use in pregnancy.10 tramadol conversion to morphine .37 V vancomycin intravenous administration .66 vitamin K reversal of anticoagulation .17 Y Yellow Card Reporting.74 and trandolapril.
Cramping or pain, onset of bleeding, clots or tissue, last normal menstrual period, method of birth control, due date if pregnant, history of vaginal trauma, number of pads or tampons per hour, past medical history, medications, referred shoulder pain. The first edition of this kit was written in 1992 by John Goodwin for the ACON Prisons Working Group. The second edition was written in 1995 by Amanda Hall, Geoffrey Bloom, and Alida Stanley. The third edition was written by David Puls and Jenny Wong. If you have any comments or enquiries regarding this kit, feel free to contact the HIV AIDS Legal Centre on 02 9206 2060.

Tinzaparin sodium inhibits reactions that lead to the clotting of blood including the formation of fibrin clots, both in vitro and in vivo and tipranavir.

Tinzaparin drug Chapter 24 Men p frsta veckodagen kommo de, tidigt i sjlva dagbrckningen, till graven med de 2 3 vlluktande kryddor som de hade tillrett. Och de funno stenen vara bortvltrad frn graven. D 4 gingo de ditin, men funno icke Herren Jesu kropp. Nr de nu icke visste vad de skulle tnka 5 hrom, se, d stodo tv man framfr dem i skinande klder. Och de blevo frskrckta och bjde sina ansikten ned mot jorden. D sade mannen till dem Varfr sken I den levande bland de dda? 6 Han r icke har, han r uppstnden. Kommen ihg vad han talade till eder, medan han nnu var i 7 Galileen, huru han sade: 'Mnniskosonen mste bliva verlmnad i syndiga mnniskors hnder 8 och bliva korsfst; men p tredje dagen skall han uppst igen.' D kommo de ihg hans ord. 9 Och de vnde tillbaka frn graven och omtalade allt detta fr de elva och fr alla de andra. -10 Kvinnorna voro Maria frn Magdala och Johanna och den Maria som var Jakobs moder. Och 11 jmvl de andra kvinnorna instmde med dem och sade detsamma till apostlarna. Deras ord 12 syntes dock fr dessa vara lst tal, och de trodde dem icke. Men Petrus stod upp och skyndade till graven; och nr han lutade sig ditin sg han dr allenast linnebindlarna. Sedan gick han hem till 13 sitt, uppfylld av frundran ver det som hade skett. Men tv av dem voro samma dag stadda p 14 vandring till en by som hette Emmaus, och som lg sextio stadiers vg frn Jerusalem. Och de 15 samtalade med varandra om allt detta som hade skett. Medan de nu samtalade och verlade med 1. Our objective was to compare tinzaparin to standard heparin during maintenance hemodialysis over an 8-week period, in regard to the visual aspect of the extracorporeal circuit, filter reuse, bleeding and time for compression of vascular access at the end of hemodialysis session, nursing time devoted to anticoagulation administration, level of satisfaction of patients and nurses, and relative cost. In addition to two years of pre-pharmacy study, a Pharm.D. has completed at least four years of graduate studies to earn a doctorate degree in pharmacy.

Tinzaparin alternative F95A TMIII ; in combination with V71L or V71F TMII ; - As both the above results added marginal support to our model, we directed our focus towards producing compensatory mutations that might help counteract one of the more destructive binding pocket changes examined earlier, namely the important F95 residue TMIII ; that upon mutation to alanine ; disrupted the hydrophobic interaction with the chain. Upon examination of our model, V71 in TMII appeared to be a good candidate for compensation of the F-95A-induced binding deficit, when changed to phenylalanine V71F ; Figure 6 ; . Thus, we investigated both V71L and V71F mutations, in conjunction with the original F95A mutation. The. Because integrins are involved in such diverse and important biological processes, study of these proteins and their ligands is of potentially great importance to both public health and commercial drug development, and recognition of this importance arose directly out of Cheresh's research.64 After discovering the role of integrins in tumor angiogenesis, Cheresh and Scripps began to receive funding from Merck KGaA, a German pharmaceutical company.65 Experiments initiated through the Scripps-Merck collaboration first included in vitro experiments designed to test basic properties of the RGD peptides provided to Cheresh by Merck, and later included in vivo experiments designed to test the therapeutic utility of the compounds in animals.66 Many of these experiments made use of Integra's patented RGD peptides as controls.67 After Integra became aware of Merck's use of its inventions, the two companies unsuccessfully attempted to negotiate a licensing arrangement; when these negotiations failed, Integra sued Merck.68 Merck, inter alia, asserted the defense of non-infringement under the safe harbor provision of 35 U.S.C. 271 e ; 1 ; .69 Though Merck sought the safe harbor protection of 271 e ; 1 ; under the theory that commercializing its therapeutic RGD peptides would require FDA approval, Integra argued that any use of its patented peptides that, like much of the Scripps research, pre-dated clinical trials, could not be specifically tied to an FDA submission under the statute's "reasonably related" clause.70 At trial, a jury agreed, awarding Integra million in damages, under a jury instruction construing the "reasonably related" clause narrowly and requiring the jury to find that Merck had infringed unless, "there was a decent prospect that the accused activities would contribute, relatively directly, to the generation of the kinds of information that are likely to be relevant in the.